PACHUK; Catherine

Patent Applications and Registrations

Patent applications and USPTO patent grants for PACHUK; Catherine.The latest application filed is for "use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell".

Company Profile

0.10.16

PACHUK; Catherine - Lansdale PA
Pachuk; Catherine - Northborough MA
Pachuk; Catherine - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Post-transcriptional Gene Silencing For Identifying Nucleic Acid Sequences That Modulate The Function Of A Cell App 20160083723 - GIORDANO; Tony ; et al.	2016-03-24
Targeting opposite strand replication intermediates of single-stranded viruses by RNAI Grant 9,198,927 - McCallus , et al. December 1, 2	2015-12-01
Hepatitis C Dsrna Effector Molecules, Expression Constructs, Compositions, And Methods Of Use App 20150315593 - McCallus; Daniel ; et al.	2015-11-05
In Vivo Delivery of Nucleic Acids to the Liver or Liver Tissue App 20150297625 - PACHUK; Catherine	2015-10-22
Use Of Post-transcriptional Gene Silencing For Identifying Nucleic Acid Sequences That Modulate The Function Of A Cell App 20150232930 - GIORDANO; Tony ; et al.	2015-08-20
Post-transcriptional gene silencing using expressed double stranded RNA Grant 9,051,566 - Giordano , et al. June 9, 2	2015-06-09
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use Grant 8,987,227 - McCallus , et al. March 24, 2	2015-03-24
In Vivo Delivery Of Nucleic Acids To The Liver Or Liver Tissue App 20140348882 - Pachuk; Catherine	2014-11-27
In Vivo Delivery Of Nucleic Acids To The Liver Or Liver Tissue App 20140349390 - Pachuk; Catherine	2014-11-27
Hepatitis C Dsrna Effector Molecules, Expression Constructs, Compositions, And Methods Of Use App 20140141512 - McCallus; Daniel ; et al.	2014-05-22
In Vivo Delivery of Nucleic Acids to the Liver or Liver Tissue App 20130344133 - PACHUK; Catherine	2013-12-26
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use Grant 8,614,198 - McCallus , et al. December 24, 2	2013-12-24
Vivo Delivery of Double Stranded RNA to an Interleukin-12 Producing Organ or Tissue App 20130302403 - PACHUK; Catherine	2013-11-14
In vivo delivery of double stranded RNA to a target cell Grant 8,524,679 - Pachuk September 3, 2	2013-09-03
In Vivo Delivery Of Double Stranded RNA To a Target Cell App 20100323001 - Pachuk; Catherine	2010-12-23
Hepatitis C Dsrna Effector Molecules, Expression Constructs, Compositions, And Methods Of Use App 20100324117 - McCallus; Daniel ; et al.	2010-12-23
Targeting Opposite Strand Replication Intermediates Of Single-stranded Viruses By Rnai App 20100267805 - McCallus; Daniel E. ; et al.	2010-10-21
Multiple-compartment Eukaryotic Expression Systems App 20090311788 - PACHUK; Catherine ; et al.	2009-12-17
Targeting Opposite Strand Replication Intermediates Of Single-stranded Viruses By Rnai App 20090137039 - McCALLUS; Daniel E. ; et al.	2009-05-28
Methods and compositions for inhibiting the function of polynucleotide sequences App 20080081792 - Pachuk; Catherine ; et al.	2008-04-03
Multiple-compartment eukaryotic expression systems App 20060183231 - Pachuk; Catherine ; et al.	2006-08-17
DNA vaccines for herpes simplex virus Grant 5,958,895 - Pachuk , et al. September 28, 1	1999-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.